Nearly 90% of patients who undergo gastric peroral endoscopic myotomy (G-POEM) for refractory gastroparesis experience some degree of clinical benefit, according to the first multicenter trial of the procedure.
Researchers in the United States, Brazil, India and South Korea followed 30 patients with gastroparesis stemming from diabetes (n=11), surgery (n=12) or an idiopathic cause (n=7) who were treated with G-POEM. Of these patients, 26 (86%) responded to the therapy (Figure). Of the 17